• Inicio
  • Resultados de la búsqueda
  • Laboratory scale UV-visible degradation of acetamiprid in aqueous marketed mixtures - Structural elucidation of photoproducts and toxicological consequences.

Laboratory scale UV-visible degradation of acetamiprid in aqueous marketed mixtures - Structural elucidation of photoproducts and toxicological consequences.

Chemosphere (2020-02-12)
Edith Nicol, Zsuzsanna Varga, Svetlana Vujovic, Stéphane Bouchonnet
RESUMEN

Acetamiprid is a neonicotinoid pesticide, which is extensively used on agricultural crops, but has a high toxic effect on beneficial insects and the human body. It is exposed to sunlight irradiation on crops but also in surface waters where it is found at a high level due to its resistance to common water treatments. The aim of the present work was to study the UV-visible photodegradation of acetamiprid, alone and in two marketed mixtures (Polysect Ultra SL® and Roseclear Ultra®). Ten photoproducts were characterized using LC-HR-MS/MS analysis. Photodegradation pathways were proposed based on the chemical structures of photoproducts and kinetic measurements; a matrix effect has been evidenced for commercial mixtures. Most photoproducts exhibit potential developmental toxicity twice higher than that of the parent compound. Regarding potential mutagenicity, all photoproducts are less toxic than acetamiprid. Estimated oral rat LD50 values show that the potential toxicities of photoproducts are similar or lower than that of acetamiprid. In vitro tests on Vibrio fischeri bacteria showed that the ecotoxicities of marketed mixtures are significantly higher than that of acetamiprid in aqueous solution; they slightly increase after UV-light exposure.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Supelco
Acetamiprid-d3, PESTANAL®, analytical standard

Redes sociales

LinkedIn icon
Twitter icon
Facebook Icon
Instagram Icon

Merck

Investigación. Desarrollo. Producción.

Somos un proveedor líder para la industria de Ciencias de la Vida con soluciones y servicios para investigación, desarrollo y producción biotecnológicos, y para desarrollo y producción de tratamientos farmacéuticos

© 2021 Merck KGaA, Darmstadt, Alemania y/o sus filiales. Todos los derechos reservados.

Queda estrictamente prohibida la reproducción sin permiso de cualquiera de los materiales de la página web.